Effects of insulin-like growth factor-I, insulin, and leucine on protein turnover and ubiquitin ligase expression in rainbow trout primary myocytes

Am J Physiol Regul Integr Comp Physiol. 2010 Feb;298(2):R341-50. doi: 10.1152/ajpregu.00516.2009. Epub 2009 Dec 9.

Abstract

The effects of insulin-like growth factor-I (IGF-I), insulin, and leucine on protein turnover and pathways that regulate proteolytic gene expression and protein polyubiquitination were investigated in primary cultures of 4-day-old rainbow trout myocytes. Supplementing media with 100 nM IGF-I increased protein synthesis by 13% (P < 0.05) and decreased protein degradation by 14% (P < 0.05). Treatment with 1 microM insulin increased protein synthesis by 13% (P < 0.05) and decreased protein degradation by 17% (P < 0.05). Supplementing media containing 0.6 mM leucine with an additional 2.5 mM leucine did not increase protein synthesis rates but reduced rates of protein degradation by 8% (P < 0.05). IGF-I (1 nM-100 nM) and insulin (1 nM-1 microM) independently reduced the abundance of ubiquitin ligase mRNA in a dose-dependent manner, with maximal reductions of approximately 70% for muscle atrophy F-box (Fbx) 32, 40% for Fbx25, and 25% for muscle RING finger-1 (MuRF1, P < 0.05). IGF-I and insulin stimulated phosphorylation of FOXO1 and FOXO4 (P < 0.05), which was inhibited by the phosphatidylinositol 3-kinase (PI 3-kinase) inhibitor wortmannin, and decreased the abundance of polyubiquitinated proteins by 10-20% (P < 0.05). Supplementing media with leucine reduced Fbx32 expression by 25% (P < 0.05) but did not affect Fbx25 nor MuRF1 transcript abundance. Serum deprivation decreased rates of protein synthesis by 60% (P < 0.05), increased protein degradation by 40% (P < 0.05), and increased expression of all ubiquitin ligases. These data suggest that, similar to mammals, the inhibitory effects of IGF-I and insulin on proteolysis occur via P I3-kinase/protein kinase B signaling and are partially responsible for the ability of these compounds to promote protein accretion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anabolic Agents / pharmacology
  • Animals
  • Blotting, Western
  • Cathepsin D / biosynthesis
  • Cathepsin D / genetics
  • Cathepsin L / biosynthesis
  • Cathepsin L / genetics
  • Cell Separation
  • Culture Media
  • Culture Media, Serum-Free
  • Dose-Response Relationship, Drug
  • F-Box Proteins / metabolism
  • Hypoglycemic Agents / pharmacology*
  • Insulin / pharmacology*
  • Insulin-Like Growth Factor I / pharmacology*
  • Leucine / pharmacology*
  • Monocytes / drug effects
  • Monocytes / enzymology
  • Monocytes / metabolism*
  • Oncorhynchus mykiss / metabolism*
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proteins / metabolism*
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Ubiquitin-Protein Ligases / biosynthesis*

Substances

  • Anabolic Agents
  • Culture Media
  • Culture Media, Serum-Free
  • F-Box Proteins
  • Hypoglycemic Agents
  • Insulin
  • Proteins
  • RNA, Messenger
  • Insulin-Like Growth Factor I
  • Ubiquitin-Protein Ligases
  • Phosphatidylinositol 3-Kinases
  • Cathepsin L
  • Cathepsin D
  • Leucine